Does Blue Cross Blue Shield of Michigan Cover Viagra?

How BCBSM Formulary Placement Works for Erectile Dysfunction Drugs

Blue Cross Blue Shield of Michigan organizes prescription drugs into a multi-tier formulary, and where a medication lands on that formulary determines your copay. Generic sildenafil sits on Tier 1 or Tier 2 (preferred generic) across most BCBSM commercial plans, which translates to the lowest cost-sharing bracket. Brand-name Viagra, by contrast, is either excluded entirely or relegated to a higher non-preferred tier with significantly steeper copays.

This distinction matters financially. A Tier 1 generic copay on a typical BCBSM PPO plan runs between $3 and $15 per fill, while a non-preferred brand on Tier 3 or Tier 4 could cost $50 to $100 or more per fill. Since Pfizer's patent on sildenafil expired in 2017 and multiple generic manufacturers now produce the drug, insurers have little incentive to cover the brand at a favorable tier 1.

The American Urological Association (AUA) 2018 guidelines on erectile dysfunction recommend phosphodiesterase type 5 (PDE5) inhibitors as first-line pharmacotherapy, stating that "sildenafil, tadalafil, vardenafil, and avanafil are all effective first-line treatments for ED" 2. Because these guidelines do not favor one PDE5 inhibitor over another, insurers like BCBSM typically prefer whichever agent offers the lowest acquisition cost. That agent is generic sildenafil.

You can verify your specific formulary placement by logging into your BCBSM member portal or calling the number on the back of your insurance card.

Generic Sildenafil vs. Brand-Name Viagra: What BCBSM Will Approve

For nearly all BCBSM members, generic sildenafil is the practical choice. It is the same active compound at the same doses (25 mg, 50 mg, 100 mg) as brand Viagra.

The FDA requires generic medications to demonstrate bioequivalence to the reference listed drug, meaning the generic must deliver the same amount of active ingredient into the bloodstream within the same timeframe 3. A 2019 systematic review published in the Journal of Sexual Medicine confirmed that generic sildenafil demonstrated comparable efficacy and safety profiles to brand-name Viagra across multiple real-world analyses 4.

If your physician writes a prescription for "Viagra" with "dispense as written" (DAW), your BCBSM plan will likely either deny the claim outright or process it at a much higher cost-sharing level. You would need to file an exception request, providing clinical justification for why the brand is medically necessary over the generic. These exception requests are approved infrequently for PDE5 inhibitors because the clinical difference between brand and generic sildenafil is negligible.

The straightforward path: ask your prescriber to write for "sildenafil" without a DAW designation. This allows the pharmacy to dispense the generic automatically, and your BCBSM plan processes it at the preferred tier.

Prior Authorization and Quantity Limits on BCBSM Plans

BCBSM imposes quantity limits on ED medications across most plan designs. The standard limit is 6 to 12 tablets per 30-day period, though some plans cap it at 6. These limits apply regardless of the prescribed dose.

Prior authorization requirements vary by plan. Many BCBSM commercial PPO and HMO plans do not require prior authorization for generic sildenafil as long as quantity limits are met and the prescriber includes an ED diagnosis code. Some self-funded employer groups administered by BCBSM, however, layer on additional utilization management including mandatory prior authorization 5.

To determine whether your specific plan requires prior authorization, check three sources: your plan's Summary of Benefits and Coverage document, the BCBSM member portal formulary search tool, and your pharmacist at the point of sale. The pharmacist can run a test claim that reveals any authorization blocks in real time before you leave the counter.

If prior authorization is required, your prescriber's office submits documentation confirming your ED diagnosis, any relevant medical history (such as diabetes, cardiovascular disease, or prior prostatectomy), and a statement that sildenafil is clinically appropriate. The AUA guidelines note that ED affects approximately 30 million men in the United States and that PDE5 inhibitors remain first-line therapy for the condition 2. Insurers rarely deny sildenafil when the clinical documentation is complete.

What BCBSM Medicare Advantage Plans Cover for ED

Medicare Part D historically excluded coverage of ED medications entirely. The Inflation Reduction Act of 2022 did not change this exclusion. If you are enrolled in a BCBSM Medicare Advantage plan with Part D, your plan is not required to cover sildenafil or any other PDE5 inhibitor for erectile dysfunction 6.

Some BCBSM Medicare Advantage plans offer supplemental drug benefits that include limited ED medication coverage as an extra benefit. These supplemental formularies, when they exist, typically cover only generic sildenafil and impose strict quantity limits (often 4 to 6 tablets per month).

One exception: sildenafil prescribed under the brand name Revatio (20 mg) for pulmonary arterial hypertension (PAH) is covered by Medicare Part D. The coverage determination is diagnosis-dependent. If your physician prescribes sildenafil for PAH using the appropriate ICD-10 code (I27.0 or I27.2), Part D processes the claim under standard formulary rules 7.

Dr. Arthur Burnett, professor of urology at Johns Hopkins Medicine and a lead author on AUA ED guidelines, has stated: "Access to ED treatment should be considered a component of comprehensive men's health care, not an optional luxury" 2. Despite this clinical perspective, Medicare coverage gaps persist for ED medications, and BCBSM Medicare Advantage members should verify supplemental benefits before assuming coverage.

Cost Breakdown: What You Will Actually Pay

Your actual out-of-pocket cost for sildenafil through BCBSM depends on four variables: your plan's tier structure, your deductible status, your copay or coinsurance percentage, and the pharmacy you use.

On a standard BCBSM commercial PPO plan with a $10 Tier 1 copay, a fill of six 100 mg sildenafil tablets costs $10 after the deductible is met. Before the deductible, you pay the pharmacy's contracted rate, which typically runs $20 to $60 for six tablets at preferred pharmacies. Retail cash prices for the same quantity can exceed $150 without insurance, so the BCBSM contracted rate represents a meaningful discount even in the deductible phase 8.

A 2022 analysis published in JAMA Network Open found that out-of-pocket spending on ED medications varied by more than 400% depending on the insurance plan, with median annual out-of-pocket costs ranging from $84 to $456 for PDE5 inhibitors 9.

Preferred pharmacies within the BCBSM network (including many Michigan-based pharmacies like Meijer, CVS, and Walgreens) offer lower contracted rates than non-preferred or out-of-network pharmacies. Mail-order pharmacy through BCBSM's OptumRx or AllianceRx Walgreens partnership can reduce per-tablet costs further, especially for 90-day fills where available.

Tablet splitting is another cost reduction strategy. Many prescribers write for sildenafil 100 mg tablets with instructions to split them in half, effectively doubling the supply for the same copay. The 100 mg and 50 mg tablets are priced identically on most formularies, so splitting yields twice the doses per fill.

Alternative ED Medications Covered by BCBSM

If sildenafil does not work for you or causes intolerable side effects, BCBSM covers several alternative PDE5 inhibitors, though at varying formulary tiers.

Generic tadalafil (Cialis) is typically covered at Tier 1 or Tier 2, similar to sildenafil. Tadalafil offers a longer duration of action (up to 36 hours compared to sildenafil's 4 to 6 hours) and is available in a daily 2.5 mg or 5 mg dose for continuous use 10. Some BCBSM plans impose step therapy that requires a trial of sildenafil before tadalafil is approved at the preferred tier.

Avanafil (Stendra) remains brand-only and sits on higher formulary tiers with correspondingly higher copays. Vardenafil is available as a generic and typically lands on Tier 2.

A meta-analysis of 82 randomized controlled trials (N = 47,626) published in The Lancet found that all four PDE5 inhibitors were significantly more effective than placebo for ED, with no statistically significant differences in efficacy between them when compared head-to-head 11. Dr. Irwin Goldstein, director of San Diego Sexual Medicine, has noted: "Choosing between PDE5 inhibitors often comes down to onset time, duration of action, and side-effect profile rather than raw efficacy differences" 11.

For men who do not respond to oral PDE5 inhibitors, BCBSM may cover second-line therapies including alprostadil (Caverject, Edex) penile injections or intraurethral suppositories (MUSE). These require prior authorization and documentation of PDE5 inhibitor failure.

How to File an Appeal if BCBSM Denies Your Claim

BCBSM denials for ED medications most commonly occur due to quantity limit overrides, brand-over-generic requests, or missing diagnosis documentation. The appeals process has defined timelines and steps.

First, request the denial letter. It specifies the exact reason for denial and cites the plan policy or clinical criteria that triggered the rejection. Second, your prescribing physician must submit a prior authorization appeal that addresses the specific denial reason. For quantity limit appeals, the physician provides clinical documentation explaining why a higher quantity is medically necessary (e.g., the patient requires more frequent dosing due to a short half-life response pattern or concurrent medications that affect drug metabolism) 12.

BCBSM must respond to standard prior authorization appeals within 72 hours for urgent requests and 30 calendar days for non-urgent requests under Michigan insurance regulations. If the internal appeal is denied, you have the right to an independent external review through the Michigan Department of Insurance and Financial Services (DIFS).

Practical tip: keep records of every phone call with BCBSM, including the representative's name, call reference number, and a summary of what was discussed. These records become valuable if the case escalates to external review.

When to Consider Cash Pay or Discount Programs Instead

In some situations, paying cash for generic sildenafil is cheaper than using your BCBSM insurance. This happens when your plan has a high deductible that has not been met, when your plan excludes ED drugs entirely, or when a discount program offers a lower price than your copay.

Pharmacy discount aggregators routinely list generic sildenafil at $8 to $25 for a fill of six 100 mg tablets at participating Michigan pharmacies. If your BCBSM plan has a $2,000 deductible and you have not met it, you would pay the full contracted rate (potentially $40 to $60) through insurance versus $10 to $15 through a discount card. In that scenario, the discount card is the better financial choice, though the purchase does not count toward your deductible.

The cost of untreated ED extends beyond the medication itself. A 2020 study in The Journal of Sexual Medicine found that men with untreated ED had 1.3 times higher rates of depression and 1.6 times higher rates of relationship dissolution compared to men receiving treatment (N = 4,832, p < 0.001) 13. The clinical and quality-of-life argument for accessing affordable treatment is strong regardless of the payment mechanism.

If you are a BCBSM member whose plan excludes ED medications, discuss the situation with your prescriber. They may identify an alternative coverage pathway, such as documenting sildenafil for off-label benign prostatic hyperplasia or Raynaud phenomenon, where clinically appropriate and supported by evidence.